Medication overuse headache: Type I and type II [2]

Cephalalgia

Volumn 26, Issue 10, 2006, Pages 1262-

  Saper, J R ^a   Lake III, A E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; OPIATE;

BEHAVIOR DISORDER; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; DRUG OVERDOSE; HUMAN; LETTER; PROGNOSIS;

ANALGESICS; HEADACHE DISORDERS, SECONDARY; HUMANS;

EID: 33748486490     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01198.x     Document Type: Letter

References (5)

1. Saper JR, Hamel RL, Lake AE III. Medication overuse headache (MOH) is a biobehavioral disorder. Cephalalgia 2005; 25:545.
2. Saper JR, Lake AE III. Borderline personality disorder and the chronic headache patient. Review and management recommendations. Headache 2002; 42:663-74.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. DSM-IV. Washington, DC: American Psychiatric Association 1994.
4. Diener HC, Limmroth V. Medication overuse headache: a worldwide problem. Lancet Neurol 2005; 3:475-83.
5. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of cox1/cox2 inhibitors. Headache 2005; 45:850-61.